In a recent clinical study, patients with treatment-resistant post-traumatic stress disorder were symptom-free up to six months after completing traditional therapy paired with vagus nerve stimulation ...

President Donald Trump's administration on Monday pushed forward in defending U.S. rules easing access to the abortion drug ...

Discover insights from Corcept Therapeutics' Q1 2025 earnings call: revenue growth, relacorilant's FDA review, and its strategic outlook ...

The biotech’s Huntingtin-targeting molecule lowered blood levels of the protein and elicited functional improvements in ...

Packs of fresh tomatoes sold in nearly a dozen states have been recalled over possible salmonella contamination, according to ...

The lawsuit was initially rejected by the Supreme Court before it was revived by Republican attorneys general in three states ...

A new study being used to call for mifepristone restrictions relies on vague and dubious definitions of drug-related ...

Federal agencies, including the FDA and the EPA, were ordered to accelerate approval of domestic manufacturing plants.

Nineteen states and the District of Columbia have filed a new lawsuit against HHS Secretary Robert F. Kennedy Jr. in hopes of ...

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

President Donald Trump vowed on the campaign trail last year not to interfere with abortion on the federal level, including access to abortion pills, opting to leave the matter to states instead.

Trump told Time magazine in December he would not restrict access to abortion medication. On the campaign trail, said ...